Yu Qianli, Vazquez Randy, Khojeini Elham Vali, Patel Chirag, Venkataramani Raj, Larson Douglas F
Surgery Department and Sarver Heart Center, College of Medicine, University of Arizona, Tucson, AZ 85724, USA.
Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H76-85. doi: 10.1152/ajpheart.01285.2008. Epub 2009 May 8.
Osteopontin (OPN), a key component of the extracellular matrix, is associated with the fibrotic process during tissue remodeling. OPN and the cytokine interleukin (IL)-18 have been shown to be overexpressed in an array of human cardiac pathologies. In the present study, we determined the role of IL-18 in the regulation of cardiac OPN expression and the subsequent interstitial fibrosis and diastolic dysfunction. We demonstrated parallel increases in IL-18, OPN expression, and interstitial fibrosis in murine models of left ventricular pressure and volume overload. Exogenous recombinant (r)IL-18 administered for 2 wk increased cardiac OPN expression, interstitial fibrosis, and diastolic dysfunction. Stimulation of the T helper (Th)1 lymphocyte phenotype with a selective toll-like receptor (TLR)9 agonist induced cardiac IL-18 and OPN expression, which was associated with increased cardiac fibrillar collagen concentrations and interstitial fibrosis resulting in diastolic dysfunction. rIL-18 induced OPN expression and protein levels in primary of cardiac fibroblast cultures. Conditioned media from TLR9-stimulated T lymphocyte cultures induced IL-18 and OPN expression in cardiac fibroblasts, while blockade of the IL-18 receptor with a neutralizing antibody abolished the increase in OPN expression. Furthermore, a mutation in the transcriptional factor interferon regulatory factor (IRF)1 or IRF1 small interfering RNA (siRNA) resulted in the decreased expression of IL-18 and OPN in cardiac fibroblasts. With pressure overload, IRF1-mutant mice showed downregulation of IL-18 and OPN expression in cardiac tissue, reduced cardiac fibrotic development, and increased left ventricular function compared with wild type. These results provide direct evidence that the induction of IL-18 regulates OPN-mediated cardiac fibrosis and diastolic dysfunction.
骨桥蛋白(OPN)是细胞外基质的关键成分,与组织重塑过程中的纤维化进程相关。OPN和细胞因子白细胞介素(IL)-18在一系列人类心脏疾病中均呈过表达。在本研究中,我们确定了IL-18在调节心脏OPN表达以及随后的间质纤维化和舒张功能障碍中的作用。我们证实在左心室压力和容量超负荷的小鼠模型中,IL-18、OPN表达和间质纤维化呈平行增加。给予外源性重组(r)IL-18 2周可增加心脏OPN表达、间质纤维化和舒张功能障碍。用选择性Toll样受体(TLR)9激动剂刺激辅助性T(Th)1淋巴细胞表型可诱导心脏IL-18和OPN表达,这与心脏纤维状胶原浓度增加和间质纤维化导致舒张功能障碍有关。rIL-18可诱导原代心脏成纤维细胞培养物中OPN的表达和蛋白水平。来自TLR9刺激的T淋巴细胞培养物的条件培养基可诱导心脏成纤维细胞中IL-18和OPN表达,而用中和抗体阻断IL-18受体可消除OPN表达的增加。此外,转录因子干扰素调节因子(IRF)1发生突变或使用IRF1小干扰RNA(siRNA)会导致心脏成纤维细胞中IL-18和OPN表达降低。压力超负荷时,与野生型相比,IRF1突变小鼠心脏组织中IL-18和OPN表达下调,心脏纤维化发展减轻,左心室功能增强。这些结果提供了直接证据,表明IL-18的诱导调节了OPN介导的心脏纤维化和舒张功能障碍。